Pallu Reddanna Selected Research

Lipids

1/2019	Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
12/2013	Molecular basis for the catalytic inactivity of a naturally occurring near-null variant of human ALOX15.
3/2011	A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pallu Reddanna Research Topics

Disease

17	Inflammation (Inflammations) 01/2022 - 10/2006
14	Neoplasms (Cancer) 01/2022 - 11/2003
4	Infections 07/2022 - 08/2010
4	Edema (Dropsy) 11/2018 - 06/2009
4	Carcinogenesis 10/2016 - 08/2008
4	Hepatocellular Carcinoma (Hepatoma) 09/2011 - 07/2007
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2008 - 08/2004
3	Virus Diseases (Viral Diseases) 07/2022 - 09/2020
3	Body Weight (Weight, Body) 01/2020 - 10/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 01/2009
2	Colitis 05/2024 - 10/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019 - 11/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2013 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2012 - 04/2012
1	Colonic Neoplasms (Colon Cancer) 05/2024
1	Ulcerative Colitis 05/2024
1	COVID-19 01/2022
1	Drug-Related Side Effects and Adverse Reactions 09/2020
1	Skin Neoplasms (Skin Cancer) 09/2019
1	Leukemia 09/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Atherosclerosis 01/2016
1	Sepsis (Septicemia) 01/2016
1	Osteoarthritis 01/2015

Drug/Important Bio-Agent (IBA)

10	EnzymesIBA 01/2019 - 10/2006
5	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2024 - 06/2002
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 03/2009
5	CarrageenanIBA 11/2018 - 08/2008
4	EicosanoidsIBA 01/2022 - 03/2009
4	AntioxidantsIBA 01/2019 - 08/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2018 - 06/2002
4	Celecoxib (Celebrex)FDA Link 01/2018 - 06/2002
4	LipoxygenasesIBA 10/2016 - 11/2009
4	LipopolysaccharidesIBA 01/2016 - 10/2006
4	PhycocyaninIBA 12/2010 - 11/2003
3	CytokinesIBA 01/2022 - 04/2018
3	LeukotrienesIBA 10/2021 - 10/2016
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2021 - 10/2015
3	ProstaglandinsIBA 01/2021 - 01/2009
3	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 09/2019 - 07/2007
3	LipidsIBA 01/2019 - 03/2011
3	Arachidonic Acid (Vitamin F)IBA 10/2016 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 08/2010 - 08/2004
2	Acetic Acid (Vinegar)FDA LinkGeneric 05/2024 - 06/2009
2	Antiviral Agents (Antivirals)IBA 07/2022 - 09/2020
2	AcidsIBA 01/2022 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 03/2009
2	Interleukin-6 (Interleukin 6)IBA 09/2019 - 12/2011
2	Ethanol (Ethyl Alcohol)IBA 04/2018 - 05/2008
2	Protein Isoforms (Isoforms)IBA 01/2016 - 03/2009
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 07/2012 - 04/2012
2	chebulagic acidIBA 09/2011 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011 - 07/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2010 - 07/2007
1	mangiferinIBA 05/2024
1	Drug CarriersIBA 01/2022
1	Dextrans (Dextran)FDA Link 10/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2021
1	inerminIBA 09/2020
1	echinoisoflavanoneIBA 09/2020
1	FlavonoidsIBA 09/2020
1	Ribavirin (Virazole)FDA LinkGeneric 09/2020
1	LigandsIBA 01/2020
1	13-hydroxy-9,11-octadecadienoic acidIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2019
1	13-hydroperoxy-9,11-octadecadienoic acidIBA 09/2019
1	15- hydroperoxy- 5,8,11,13- eicosatetraenoic acidIBA 09/2019
1	Phospholipases A2 (Phospholipase A2)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	AutoantibodiesIBA 01/2019
1	Phospholipase A2 ReceptorsIBA 01/2019
1	Cyclooxygenase 1IBA 04/2018
1	ethyl acetateIBA 04/2018
1	naphthaIBA 04/2018
1	NanoconjugatesIBA 01/2018
1	GenisteinIBA 10/2016
1	ResveratrolIBA 10/2016
1	fisetinIBA 10/2016
1	BerberineIBA 10/2016
1	Ellagic AcidIBA 10/2016
1	EugenolIBA 10/2016
1	ApigeninIBA 10/2016
1	LycopeneIBA 10/2016
1	gingerolIBA 10/2016
1	CurcuminIBA 10/2016
1	baicaleinIBA 10/2016
1	Ursolic AcidIBA 10/2016
1	Masoprocol (Actinex)FDA Link 10/2016
1	Phospholipases (Phospholipase)IBA 10/2016
1	Secretory Phospholipases A2IBA 01/2016
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	CG100649IBA 01/2015
1	Inflammation MediatorsIBA 01/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2013

Therapy/Procedure

2	Therapeutics 07/2022 - 10/2016
1	Quantum Dots (Quantum Dot) 01/2018
1	Ligation 01/2016
1	Punctures 01/2016